2023
DOI: 10.1016/j.brs.2022.12.011
|View full text |Cite
|
Sign up to set email alerts
|

Robust enhancement of motor sequence learning with 4 mA transcranial electric stimulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 95 publications
3
9
0
Order By: Relevance
“…The prominent benefit to learning in the highest intensity 4mA condition suggests that higher doses of injected current can be more potent in modulating function. This result is consistent with previous findings of large benefits of 4mA tDCS on sequence learning in neurotypical young adults (Hsu et al, 2023; Shinde et al, 2021). Similarly, positive dose-response relationships have been suggested from meta-analyses on clinical populations such as those who have had a stroke (Van Hoornweder et al, 2021) or major depression (Wang et al, 2021).…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…The prominent benefit to learning in the highest intensity 4mA condition suggests that higher doses of injected current can be more potent in modulating function. This result is consistent with previous findings of large benefits of 4mA tDCS on sequence learning in neurotypical young adults (Hsu et al, 2023; Shinde et al, 2021). Similarly, positive dose-response relationships have been suggested from meta-analyses on clinical populations such as those who have had a stroke (Van Hoornweder et al, 2021) or major depression (Wang et al, 2021).…”
Section: Discussionsupporting
confidence: 93%
“…One possible reason for these inconsistencies is the use of varied stimulation protocols, driven by the fact we do not fully understand how stimulation modulates the brain. Indeed, it has recently been suggested that the some dosages (intensity) of stimulation applied to the motor cortex (0.7 - 1mA) may not be enough to produce reliable effects, and indeed intensities as high as 4mA may be required to achieve this (Hsu, Shereen, Cohen, & Parra, 2023; Shinde, Lerud, Munsch, Alsop, & Schlaug, 2021) .…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, recent research in humans showed that tDCS delivered at 4 mA intensity can robustly enhance the effects of the stimulation compared to 2 mA and is safe, well-tolerated and without adverse effects (e.g., (Michael A. Nitsche and Bikson 2017; Roncero et al 2021; Hsu et al 2023). Therefore, our results encourage further investigation using anodal prefrontal HD-tDCS at an intensity of 4 mA to non-invasively attempt to reverse the effects of deep propofol anaesthesia.…”
Section: Discussionmentioning
confidence: 99%
“…The use of electrical brain stimulation (EBS) as a therapeutic modality for treatment of brain disorders has evolved significantly, with recent developments pushing pathway activation, etc., to treat Parkinson's disease (PD), Alzheimer's disease (AD), and other central nervous system (CNS) disorders. [6][7][8][9][10][11][12][13][14] Take treatment for AD as an example, studies have suggested that the use of 40 Hz flicker stimulation can modulate abnormal gamma oscillations in the brain waves of AD model mice to some extent, thereby improving impaired learning and memory functions. [15][16][17] However, the latest research refutes this finding, claiming that flicker stimulation cannot regulate gamma oscillations in brain waves, nor can it reduce excessive Aβ deposition in the brains of AD mice or ameliorate AD symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…The use of electrical brain stimulation (EBS) as a therapeutic modality for treatment of brain disorders has evolved significantly, with recent developments pushing the boundaries of our understanding and treatment capabilities 1–6 . The principle of this approach is to use precisely applied electrical currents to modulate neuronal activity, such as neuronal membrane stability and action potential, ion and neurotransmitter fluxes, intracellular pathway activation, etc., to treat Parkinson's disease (PD), Alzheimer's disease (AD), and other central nervous system (CNS) disorders 6–14 …”
Section: Introductionmentioning
confidence: 99%